Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain

Journal of Clinical Microbiology

Volumn 51, Issue 6, 2013, Pages 1927-1930

  Barrado, Laura ^a   Brañas, Patricia ^a   Orellana, M Ángeles ^a   Martínez, M Teresa ^a   García, Gloria ^a   Otero, Joaquín R ^a   Chaves, Fernando ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACHROMOBACTER; ACHROMOBACTER INFECTION; ACHROMOBACTER INSOLITUS; ACHROMOBACTER PULMONIS; ACHROMOBACTER RUHLANDII; ACHROMOBACTER SPIRITINUS; ACHROMOBACTER XYLOSOXIDANS; ADULT; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; MALE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS; SPAIN;

ACHROMOBACTER; ADOLESCENT; ADULT; BACTERIAL PROTEINS; CHILD; CYSTIC FIBROSIS; DNA, BACTERIAL; FEMALE; GENOTYPE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MOLECULAR TYPING; SEQUENCE ANALYSIS, DNA; SPAIN; YOUNG ADULT;

ACHROMOBACTER; ACHROMOBACTER XYLOSOXIDANS;

EID: 84878522882     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00494-13     Document Type: Article

References (21)

1. Lipuma JJ. 2010. The changing microbial epidemiology in cystic fibrosis. Clin. Microbiol. Rev. 23:299-323.
2. Spilker T, Vandamme P, Lipuma JJ. 2012. A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species. J. Clin. Microbiol. 50:3010-3015.
3. Spilker T, Vandamme P, Lipuma JJ. 6 November 2012. Identification and distribution of Achromobacter species in cystic fibrosis. J. Cyst. Fibros. [Epub ahead of print.] doi:10.1016/j.jcf.2012.10.002.
4. Vandamme P, Moore ER, Cnockaert M, De Brandt E, Svensson-Stadler L, Houf K, Spilker T, Lipuma JJ. 6 December 2012. Achromobacter animicus sp. nov., Achromobacter mucicolens sp. nov., Achromobacter pulmonis sp. nov. and Achromobacter spiritinus sp. nov., from human clinical samples. Syst. Appl. Microbiol. [Epub ahead of print.] doi:10.1016/j.syapm.2012.10.003.
5. Ridderberg W, Wang M, Norskov-Lauritsen N. 2012. Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans. J. Clin. Microbiol. 50:2688-2694.
6. National Committee for Clinical Laboratory Standards. 2011. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. M100-S21. NCCLS, Wayne, PA.
7. Turton JF, Mustafa N, Shah J, Hampton CV, Pike R, Kenna DT. 2011. Identification of Achromobacter xylosoxidans by detection of the bla(OXA-114-like) gene intrinsic in this species. Diagn. Microbiol. Infect. Dis. 70: 408-411.
8. Riccio ML, Pallecchi L, Docquier JD, Cresti S, Catania MR, Pagani L, Lagatolla C, Cornaglia G, Fontana R, Rossolini GM. 2005. Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-β- lactamase from different Italian hospitals. Antimicrob. Agents Chemother. 49:104-110. (Pubitemid 40065779)
9. Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, Louden L, Ramsey BW, Clausen CR. 1998. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin. Infect. Dis. 27:158-163. (Pubitemid 28334435)
10. De Baets F, Schelstraete P, Van Daele S, Haerynck F, Vaneechoutte M. 2007. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J. Cyst. Fibros. 6:75-78. (Pubitemid 46029892)
11. Kanellopoulou M, Pournaras S, Iglezos H, Skarmoutsou N, Papafrangas E, Maniatis AN. 2004. Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. Eur. J. Clin. Microbiol. Infect. Dis. 23:336-339. (Pubitemid 38669944)
12. Lambiase A, Catania MR, Del Pezzo M, Rossano F, Terlizzi V, Sepe A, Raia V. 2011. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 30:973-980.
13. Pereira RH, Carvalho-Assef AP, Albano RM, Folescu TW, Jones MC, Leão RS, Marques EA. 2011. Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients. J. Clin. Microbiol. 49: 3649-3651.
14. Raso T, Bianco O, Grosso B, Zucca M, Savoia D. 2008. Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients. APMIS 116:837-841.
15. Razvi S, Quittell L, Sewall A, Quinton H, Marshall B, Saiman L. 2009. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest 136:1554-1560.
16. Steinkamp G, Wiedemann B, Rietschel E, Krahl A, Gielen J, Bärmeier H, Ratjen F, Emerging Bacteria Study Group. 2005. Prospective evaluation of emerging bacteria in cystic fibrosis. J. Cyst. Fibros. 4:41-48. (Pubitemid 40347776)
17. Hansen CR, Pressler T, Nielsen KG, Jensen PO, Bjarnsholt T, Hoiby N. 2010. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J. Cyst. Fibros. 9:51-58.
18. Bador J, Amoureux L, Blanc E, Neuwirth C. 2013. Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump. Antimicrob. Agents Chemother. 57: 603-605.
19. Moissenet D, Baculard A, Valcin M, Marchand V, Tournier G, Garbarg- Chenon A, Vu-Thien H. 1997. Colonization by Alcaligenes xylosoxidans in children with cystic fibrosis: a retrospective clinical study conducted by means of molecular epidemiological investigation. Clin. Infect. Dis. 24: 274-275. (Pubitemid 27081560)
20. Krzewinski JW, Nguyen CD, Foster JM, Burns JL. 2001. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J. Clin. Microbiol. 39:3597-3602. (Pubitemid 32954508)
21. Doi Y, Poirel L, Paterson DL, Nordmann P. 2008. Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans. Antimicrob. Agents Chemother. 52:1952-1956. (Pubitemid 351758529)